The Very Real Nightmare of Sleep Apnea Treatments

Key Points:

• Obstructive sleep apnea (OSA) affects an estimated 84 million adults in the U.S., with 80% of cases undiagnosed, causing serious health risks like heart problems, cognitive decline, and mood disorders if untreated.
• Continuous positive airway pressure (CPAP) machines are the gold standard treatment but suffer from low adherence rates due to discomfort, claustrophobia, and maintenance challenges, with only about 38–45% of users maintaining regular use.
• Alternatives to CPAP include surgically implanted devices like Inspire, mandibular advancement devices (MADs), and recently FDA-approved drugs such as Zepbound, though these options vary in effectiveness, cost, and patient eligibility.
• New treatments in development, including a neuromuscular modulator pill by Apnimed, show promise for easier management of sleep apnea but are still undergoing clinical trials and regulatory approval.
• Experts emphasize the importance of diagnosis and treatment adherence, as managing sleep apnea significantly improves quality of life and reduces health risks, despite the challenges patients face in finding the right therapy.